The latest data concluded that taking tirzepatide resulted in clinically meaningful and sustained weight loss for at least 3 years, and it also led to limited weight gain.
Lancet (London, England), 402 (10401), 529544
Conditions like dandruff, seborrheic dermatitis, or scalp psoriasis create environments that inhibit hair growth regardless of peptide use
The FDA notes that compounded injectable products containing GHK-Cu may carry immunogenicity concerns related to aggregation and peptide impurities, while human safety data for injectable routes remain limited
The mechanism of ferroptosis is based on severe iron-dependent lipid peroxidation and ROS [226, 227]
A study in Cell Metabolism confirmed that the reduction in sleeping metabolic rate and 24-hour energy expenditure was comparable between tirzepatide and placebo groups after adjusting for changes in body weight